The University Hospital Zurich (USZ) has recently initiated an independent, cutting-edge clinical study to assess the efficiency of Steriwave®, the antimicrobial photodynamic therapy by the Canadian company, Ondine Biomedical Inc. This is yet another significant milestone in Ondine's mission to offer innovative solutions for infection prevention and limit the growing global concern of antimicrobial resistance.
Deployed…
Canadian life sciences firm Ondine Biomedical, well-known for its pioneering in light-activated antimicrobial therapies, has garnered regulatory approval to introduce its Steriwave nasal decolonization product in the United Arab Emirates (UAE), a significant breakthrough towards reducing healthcare-associated infections (HAIs) in surgical patients. The booming healthcare industry in the UAE, which has emerged as a medical…